US working with drug firm on new coronavirus treatment

13 Sept 10:49 Key points summarised by AI

The US Department of Health and Human Services (HHS) is partnering with pharmaceutical company Regeneron to develop a new treatment for the 2019 Novel Coronavirus.
This treatment focuses on monoclonal antibodies, a form of immunotherapy that neutralizes the virus, distinct from other approaches like antiretrovirals or flu drugs.
Regeneron has a track record with similar technology, having developed effective monoclonal antibody treatments for Ebola and Middle East Respiratory Syndrome (MERS).
Beyond this new partnership, doctors and researchers are also exploring other therapeutic avenues, including HIV drugs, anti-flu medications, and the antiviral remdesivir.
In a separate development, the US Food and Drug Administration (FDA) expanded the availability of a coronavirus detection test to qualified laboratories nationwide, as the US confirms 11 cases.

Six injured after car smashes into On Nut shopping mall

Yesterday 22:44 Key points summarised by AI

A 67-year-old woman drove her car through the glass frontage of a Bangkok shopping mall, injuring six people, including a six-year-old girl.
The driver claimed she accidentally pressed the accelerator instead of the brake after being startled, causing the vehicle to surge forward.
She apologized to the victims, promising insurance coverage and additional financial aid, while police continue to gather statements before filing charges.